CYNTHIA ANN GUZZO
Medical Practice in Meadowbrook, PA

License number
Pennsylvania MD030667E
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
Meadowbrook, PA 19046

Professional information

Cynthia Guzzo Photo 1

Method For Treating Pediculosis Capitisinfestation

US Patent:
6262031, Jul 17, 2001
Filed:
Mar 10, 2000
Appl. No.:
9/523335
Inventors:
Stephanie Larouche - Princeton Junction NJ
Cynthia Guzzo - Rydal PA
Alfred J. Saah - Blue Bell PA
Kenneth Brown - Philadelphia PA
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
A61K 3170
US Classification:
514 30
Abstract:
A method for treating Pediculosis capitis infestation in a human patient which comprises orally administering to the human a total amount of ivermectin of between about 400 ug/kg and about 1200 ug/kg over a period of time of about one week, wherein equal portions of the total amount are administered according to an administration sequence selected from the group consisting of c) a first day and a second day, and d) a first day, a second day and a third day, during the one week time period. The invention is also a method for treating Pediculosis capitis infestation in a human patient which comprises orally administering to the human a total amount of ivermectin of between about 6 mg and 135 mg over a period of time of about one week, wherein equal portions of the total amount are administered according to an administration sequence selected from the group consisting of e) a first day and a second day, and f) a first day, a second day and a third day, during the one week time period.


Cynthia Guzzo Photo 2

Topical Ivermectin Composition

US Patent:
7064108, Jun 20, 2006
Filed:
Feb 4, 2003
Appl. No.:
10/504262
Inventors:
Cynthia A. Guzzo - Rydal PA, US
Coleen M. Clineschmidt - Perkiomenville PA, US
George Schorn - North Wales PA, US
James M. Reynolds - Harleysville PA, US
Assignee:
Merck & Co., Inc. - Rahway NJ
McNeil-PPC, Inc. - Fort Washington PA
International Classification:
A01N 43/04, A61K 31/70
US Classification:
514 27, 514 30
Abstract:
A topical gel composition comprising between about 0. 005 and 1. 0% ivermectin, between about 30 and 40% of a pharmaceutically acceptable alcohol, between about 30 and 40% of a pharmaceutically acceptable glycol, and a pharmaceutically acceptable carrier, useful for treating Pediculosis capitis infestation in a human patient.